These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37498992)

  • 1. Synergistic anti-tumour activity of ginsenoside Rg3 and doxorubicin on proliferation, metastasis and angiogenesis in osteosarcoma by modulating mTOR/HIF-1α/VEGF and EMT signalling pathways.
    Zeng X; Liu S; Yang H; Jia M; Liu W; Zhu W
    J Pharm Pharmacol; 2023 Nov; 75(11):1405-1417. PubMed ID: 37498992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells.
    Kim JW; Jung SY; Kwon YH; Lee JH; Lee YM; Lee BY; Kwon SM
    Cancer Biol Ther; 2012 May; 13(7):504-15. PubMed ID: 22406998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenosides Inhibit the Proliferation of Lung Cancer Cells and Suppress the Rate of Metastasis by Modulating EGFR/VEGF Signaling Pathways.
    Yu X; Wang Q; Dai Z
    J Oleo Sci; 2024; 73(2):219-230. PubMed ID: 38311411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway.
    Cao Y; Ye Q; Zhuang M; Xie S; Zhong R; Cui J; Zhou J; Zhu Y; Zhang T; Cao L
    PLoS One; 2017; 12(11):e0186520. PubMed ID: 29140979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg3 inhibits HIF-1α and VEGF expression in patient with acute leukemia via inhibiting the activation of PI3K/Akt and ERK1/2 pathways.
    Zeng D; Wang J; Kong P; Chang C; Li J; Li J
    Int J Clin Exp Pathol; 2014; 7(5):2172-8. PubMed ID: 24966925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg3 Suppresses Proliferation and Induces Apoptosis in Human Osteosarcoma.
    Li Y; Lu J; Bai F; Xiao Y; Guo Y; Dong Z
    Biomed Res Int; 2018; 2018():4306579. PubMed ID: 29750154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
    Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
    Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells.
    Zhang YH; Li HD; Li B; Jiang SD; Jiang LS
    Oncol Rep; 2014 Feb; 31(2):919-25. PubMed ID: 24337872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model.
    Oshiro H; Tome Y; Miyake K; Higuchi T; Sugisawa N; Kanaya F; Nishida K; Hoffman RM
    Sci Rep; 2021 Apr; 11(1):8583. PubMed ID: 33883561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study for the roles and mechanisms of 20(R)-ginsenoside Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice].
    Geng L; Fan J; Gao QL; Yu J; Hua BJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 48(3):496-501. PubMed ID: 27318914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice.
    Liu TG; Huang Y; Cui DD; Huang XB; Mao SH; Ji LL; Song HB; Yi C
    BMC Cancer; 2009 Jul; 9():250. PubMed ID: 19624862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Rg3 alleviates the migration, invasion, and angiogenesis of lung cancer cells by inhibiting the expressions of cyclooxygenase-2 and vascular endothelial growth factor.
    Lv Q; Xia Z; Huang Y; Ruan Z; Wang J; Huang Z
    Chem Biol Drug Des; 2023 Apr; 101(4):937-951. PubMed ID: 36593682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent Akt/eNOS signaling.
    Kim JW; Jung SY; Kwon YH; Lee SH; Lee JH; Lee BY; Kwon SM
    Phytother Res; 2012 Sep; 26(9):1286-93. PubMed ID: 22253055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory Effect of Ginsenoside Rg3 Combined With 5-Fluorouracil on Tumor Angiogenesis and Tumor Growth of Colon Cancer in Mice: An Experimental Study].
    Zhao Y; Deng L; Cao Y; Ma B; Li Y; Xu J; Li H; Huang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):111-117. PubMed ID: 38322531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a miR-516b-5p/KPNA4-dependent manner.
    Wang T; Zhang C; Wang S
    J Orthop Surg Res; 2021 Dec; 16(1):724. PubMed ID: 34930332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginsenoside Rg3 enhances radiosensitization of hypoxic oesophageal cancer cell lines through vascular endothelial growth factor and hypoxia inducible factor 1α.
    Ge X; Zhen F; Yang B; Yang X; Cai J; Zhang C; Zhang S; Cao Y; Ma J; Cheng H; Sun X
    J Int Med Res; 2014 Jun; 42(3):628-40. PubMed ID: 24691458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the hypoxia-induced factor-1α and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells.
    Li B; Qu G
    J Cancer Res Ther; 2019; 15(7):1642-1646. PubMed ID: 31939450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT; Tang F; Hu X; Zheng CX; Gong TJ; Zhou Y; Luo Y; Min L
    IUBMB Life; 2020 Oct; 72(10):2146-2153. PubMed ID: 33448097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
    Liu T; Zuo L; Guo D; Chai X; Xu J; Cui Z; Wang Z; Hou C
    Biomed Pharmacother; 2019 Dec; 120():109483. PubMed ID: 31629252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of ginsenoside Rg3 on ovarian cancer metastasis.
    Xu TM; Cui MH; Xin Y; Gu LP; Jiang X; Su MM; Wang DD; Wang WJ
    Chin Med J (Engl); 2008 Aug; 121(15):1394-7. PubMed ID: 18959116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.